Licensing technologies to and working with big pharma: from discovery to market. — ASN Events
  1. Schedule
  2. Session 3 Commercialization Workshop
  3. Licensing technologies to and working with big pharma: from discovery to market.

Licensing technologies to and working with big pharma: from discovery to market. (#12)

Marc Mansour 1
  1. Chief Scientific Officer, Immunovaccine Inc, Halifax, Nova Scotia, Canada

The following topics will be discussed:

-  Pros and cons of a licensing agreement: licensor’s perspective.   

-  Effective Licensor-licensee relationship management.        

-  Licensor involvement after licensing to accelerate product development.